Statement of Ownership (sc 13g)
July 10 2020 - 3:07PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
SCHEDULE 13G
Under the Securities Exchange Act of
1934
(Amendment No. __)*
Innovation
Pharmaceuticals Inc.
(Name of Issuer)
|
|
Common
Stock Class A, $0.0001 par value
(Title of Class of Securities)
|
|
15115V101
(CUSIP Number)
|
|
June 29,
2020
(Date of Event Which Requires Filing of
this Statement)
|
Check the appropriate box to designate the rule pursuant to
which this Schedule is filed:
* The remainder of
this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities,
and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.
The information required on the remainder of this cover page
shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 or otherwise subject
to the liabilities of that section of the Act but shall be subject to all other provisions of the Act.
CUSIP NO. 15115V101
|
13G
|
Page 2 of 4 Pages
|
1
|
|
NAME OF REPORTING PERSON:
Leviston Resources LLC
|
|
|
|
2
|
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
|
|
(a) ☐
|
|
|
|
|
(b) ☐
|
|
|
|
|
|
|
3
|
|
SEC USE ONLY
|
|
|
|
|
|
|
|
|
4
|
|
CITIZENSHIP OR PLACE OF ORGANIZATION
|
|
|
Delaware
|
|
|
|
|
|
5
|
|
SOLE VOTING POWER
|
NUMBER OF
|
|
|
|
16,665,734 shares of Common Stock Class A
|
SHARES
|
|
|
BENEFICIALLY
|
|
6
|
|
SHARED VOTING POWER
|
OWNED
|
|
|
|
None
|
BY
|
|
|
EACH
|
|
7
|
|
SOLE DISPOSITIVE POWER
|
REPORTING
|
|
|
|
16,665,734 shares of Common Stock Class A
|
PERSON
|
|
|
WITH:
|
|
8
|
|
SHARED DISPOSITIVE POWER
|
|
|
|
|
None
|
9
|
|
AGGREGATE AMOUNT BENEFICIALLY
OWNED BY EACH REPORTING PERSON
|
|
|
|
|
16,665,734 shares of Common Stock Class A
|
|
|
|
10
|
|
CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
|
|
☐
|
|
|
|
|
|
|
11
|
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
|
|
|
|
|
5.2%
|
|
|
|
12
|
|
TYPE OF REPORTING PERSON*
|
|
|
|
|
OO
|
|
|
CUSIP NO. 15115V101
|
13G
|
Page 3 of 4 Pages
|
|
ITEM 1(a).
|
NAME OF ISSUER:
|
Innovation Pharmaceuticals Inc.
|
ITEM 1(b).
|
ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES:
|
301 Edgewater Place, Suite 100
Wakefield, MA
|
ITEM 2(a).
|
NAME OF PERSON FILING:
|
This Schedule 13G is being filed on behalf of the following:
|
(i)
|
Leviston Resources LLC
|
|
ITEM 2(b).
|
ADDRESS OF PRINCIPAL BUSINESS OFFICE:
|
Address of principal business or, if none,
residence:
|
(i)
|
155 E 44th St, New York, NY 10017
|
|
(i)
|
Leviston Resources LLC
is a Delaware limited liability company
|
|
ITEM 2(d).
|
TITLE OF CLASS OF SECURITIES:
|
Common Stock Class A, $0.0001 par value
15115V101
|
ITEM 3.
|
IF THIS STATEMENT IS FILED PURSUANT TO RULE 13d-1(b),
or 13d-2(b) or (c) CHECK WHETHER THE PERSON FILING IS A:
|
(a) ☐ Broker or dealer registered under section 15 of the
Act (15 U.S.C. 78o);
(b) ☐ Bank as defined in section 3(a)(6) of the Act (15 U.S.C.
78c);
(c) ☐ Insurance company as defined in section 3(a)(19) of
the Act (15 U.S.C. 78c);
(d) ☐ Investment company registered under section 8 of the
Investment Company Act of 1940 (15 U.S.C 80a-8);
(e) ☐ An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f) ☐ An employee benefit plan or endowment fund in accordance
with § 240.13d-1(b)(1)(ii)(F);
(g) ☐ A parent holding company or control person in accordance
with § 240.13d-1(b)(1)(ii)(G);
(h) ☐ A savings associations as defined in Section 3(b) of
the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i) ☐ A church plan that is excluded from the definition of
an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j) ☐ A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J);
(k) ☐ Group, in accordance with § 240.13d-1(b)(1)(ii)(K).
If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution: ____
CUSIP NO. 15115V101
|
13G
|
Page 4 of 4 Pages
|
(a)
|
Amount beneficially owned:
|
16,665,734 shares of Common Stock Class A
|
(b)
|
Percent of class:
|
5.2%
|
(c)
|
Number of shares as to which the person has:
|
|
|
(i)
|
Sole power to vote or to direct the vote:
|
16,665,734 shares of Common Stock Class A
|
|
(ii)
|
Shared power to vote or to direct the vote:
|
None
|
|
(iii)
|
Sole power to dispose or to direct the disposition of:
|
16,665,734 shares of Common Stock Class A
|
|
(iv)
|
Shared power to dispose or to direct the disposition of:
|
None
|
|
ITEM 5.
|
OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS:
|
If this statement is being filed to report the fact that as of the date hereof
the Reporting Persons have ceased to be the beneficial owner of more than five percent of the class of securities check the following. ☐
|
ITEM 6.
|
OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER
PERSON:
|
Not applicable.
|
ITEM 7.
|
IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY
WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY:
|
Not
applicable.
|
ITEM 8.
|
IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF A
GROUP:
|
Not applicable.
|
ITEM 9.
|
NOTICE OF DISSOLUTION OF GROUP:
|
Not applicable.
By signing below I
certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the
purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and
are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely
in connection with a nomination under §240.14a-11.
After reasonable inquiry
and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
|
LEVISTON RESOURCES LLC
|
|
|
|
|
By:
|
/s/ J. Miller
|
|
Name:
|
J. Miller
|
|
Date:
|
July 10, 2020
|
Innovation Pharmaceuticals (CE) (USOTC:IPIX)
Historical Stock Chart
From Aug 2024 to Sep 2024
Innovation Pharmaceuticals (CE) (USOTC:IPIX)
Historical Stock Chart
From Sep 2023 to Sep 2024